IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Abingworth LLP

Q1 2014 Holdings

Filed 2014-05-21 | 13 holdings | $181.2K | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
ProsensaCommonN71546100$34.9K6,213,92419.2%
Dicerna(DRNAUSD)Common253031108$33.3K1,182,19618.4%
Supernus(SUPN)Common868459108$32.1K3,600,00017.7%
PortolaCommon737010108$32.1K1,240,91217.7%
AmarinSpons ADR023111206$14.6K8,087,4868.1%
CempraCommon15130J109$8.2K714,2854.5%
Oncogenex PharmaCommon68230A106$7.1K603,7403.9%
ZogenixCommon98978L105$6.6K2,335,2183.7%
GW Pharma (US)Spons ADR36197T103$6.1K102,2003.3%
RegulusCommon75915K101$2.9K327,3501.6%
HyperionCommon44915N101$1.6K62,5000.9%
AntheraCommon03674U102$1.5K437,9940.8%
ZalicusCommon98887C105$9678,9660.1%